The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schulze-Koops, H.
Right arrow Articles by Davis, L. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schulze-Koops, H.
Right arrow Articles by Davis, L. S.

The Journal of Immunology, Vol 155, Issue 10 5029-5037, Copyright © 1995 by American Association of Immunologists


ARTICLES

Elevated Th1- or Th0-like cytokine mRNA in peripheral circulation of patients with rheumatoid arthritis. Modulation by treatment with anti- ICAM-1 correlates with clinical benefit

H Schulze-Koops, PE Lipsky, AF Kavanaugh and LS Davis
University of Texas Southwestern Medical Center, Harold C. Simmons Arthritis Research Center, Department of Internal Medicine, Dallas, TX 75235, USA.

The current studies examined whether cytokine patterns indicative of an imbalance in Th1 and Th2 cells could be identified in PBMC of patients with active rheumatoid arthritis (RA). To investigate this possibility, a reproducible PCR technique to assess cytokine mRNA levels in PBMC was employed that minimized in vitro manipulation of the cells. Seven of 14 RA patients had increased mRNA levels for IL-2, 5/14 for IFN-gamma, 3/14 for IL-4, and 4/14 for the IL-2R alpha-chain, compared with normal donors. Whereas 4 patients had elevated mRNA for IL-2 and IFN-gamma, indicative of an increase in activated Th1 or Th0 cells, 1 of 14 patients expressed low levels of IL-2 and IFN-gamma and high levels of IL-4 mRNA. Seven RA patients were treated with a mAb to ICAM-1 (CD54). To determine whether changes in cytokine mRNA levels might be associated with and/or account for the anti-inflammatory effect of anti- ICAM-1 mAb therapy, changes in cytokine mRNA levels were assessed and correlated with clinical improvement. Anti-ICAM-1 mAb administration was followed by a prompt and transient increase of IFN-gamma mRNA. Elevation of IFN-gamma mRNA expression throughout the treatment period reflected a temporary increase in the number of circulating CD3+CD4+ T cells, suggestive of altered circulatory patterns of activated Th1-like cells and was related to clinical efficacy. The results indicate that elevated cytokine mRNA levels characteristic for Th1 cells can be detected in the PBMC in active RA and, furthermore, that anti-ICAM-1 mAb may be beneficial in RA by altering the recruitment of activated Th1-like cells into the synovium. This assumption further strengthens the hypothesis of a significant contribution of Th1-like cells to the pathogenesis of RA.


This article has been cited by other articles:


Home page
J. Immunol.Home page
N. Young, N. Mikhalkevich, Y. Yan, D. Chen, and W.-p. Zheng
Differential Regulation of Osteoblast Activity by Th Cell Subsets Mediated by Parathyroid Hormone and IFN-{gamma}
J. Immunol., December 15, 2005; 175(12): 8287 - 8295.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Skapenko, J. R. Kalden, P. E. Lipsky, and H. Schulze-Koops
The IL-4 Receptor {alpha}-Chain-Binding Cytokines, IL-4 and IL-13, Induce Forkhead Box P3-Expressing CD25+CD4+ Regulatory T Cells from CD25-CD4+ Precursors
J. Immunol., November 1, 2005; 175(9): 6107 - 6116.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
A. N. Bennett, M. Wong, A. Zain, G. Panayi, and B. Kirkham
Adalimumab-induced asthma
Rheumatology, September 1, 2005; 44(9): 1199 - 1200.
[Full Text] [PDF]


Home page
Ann Rheum DisHome page
M Cutolo and G J M Maestroni
The melatonin-cytokine connection in rheumatoid arthritis
Ann Rheum Dis, August 1, 2005; 64(8): 1109 - 1111.
[Full Text] [PDF]


Home page
Ann Rheum DisHome page
D Y Chen, J L Lan, F J Lin, T Y Hsieh, and M C Wen
Predominance of Th1 cytokine in peripheral blood and pathological tissues of patients with active untreated adult onset Still's disease
Ann Rheum Dis, October 1, 2004; 63(10): 1300 - 1306.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
H. Schotte, B. Schluter, P. Willeke, E. Mickholz, M. A. Schorat, W. Domschke, and M. Gaubitz
Long-term treatment with etanercept significantly reduces the number of proinflammatory cytokine-secreting peripheral blood mononuclear cells in patients with rheumatoid arthritis
Rheumatology, August 1, 2004; 43(8): 960 - 964.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Skapenko, G. U. Niedobitek, J. R. Kalden, P. E. Lipsky, and H. Schulze-Koops
Generation and Regulation of Human Th1-Biased Immune Responses In Vivo: A Critical Role for IL-4 and IL-10
J. Immunol., May 15, 2004; 172(10): 6427 - 6434.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
M Cutolo, B Seriolo, C Craviotto, C Pizzorni, and A Sulli
Circadian rhythms in RA
Ann Rheum Dis, July 1, 2003; 62(7): 593 - 596.
[Full Text] [PDF]


Home page
Ann Rheum DisHome page
M Rudwaleit, B Andermann, R Alten, H Sorensen, J Listing, A Zink, J Sieper, and J Braun
Atopic disorders in ankylosing spondylitis and rheumatoid arthritis
Ann Rheum Dis, November 1, 2002; 61(11): 968 - 974.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Dimitrova, A. Skapenko, M. L. Herrmann, R. Schleyerbach, J. R. Kalden, and H. Schulze-Koops
Restriction of De Novo Pyrimidine Biosynthesis Inhibits Th1 Cell Activation and Promotes Th2 Cell Differentiation
J. Immunol., September 15, 2002; 169(6): 3392 - 3399.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
L. S. Davis, M. Sackler, R. I. Brezinschek, E. Lightfoot, J. L. Bailey, N. Oppenheimer-Marks, and P. E. Lipsky
Inflammation, Immune Reactivity, and Angiogenesis in a Severe Combined Immunodeficiency Model of Rheumatoid Arthritis
Am. J. Pathol., January 1, 2002; 160(1): 357 - 367.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Skapenko, P. E. Lipsky, H.-G. Kraetsch, J. R. Kalden, and H. Schulze-Koops
Antigen-Independent Th2 Cell Differentiation by Stimulation of CD28: Regulation Via IL-4 Gene Expression and Mitogen-Activated Protein Kinase Activation
J. Immunol., April 1, 2001; 166(7): 4283 - 4292.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
P. Hilliquin, Y. Allanore, J. Coste, M. Renoux, A. Kahan, and C. J. Menkes
Reduced incidence and prevalence of atopy in rheumatoid arthritis. Results of a case-control study
Rheumatology, September 1, 2000; 39(9): 1020 - 1026.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Gerli, C. Pitzalis, O. Bistoni, B. Falini, V. Costantini, A. Russano, and C. Lunardi
CD30+ T Cells in Rheumatoid Synovitis: Mechanisms of Recruitment and Functional Role
J. Immunol., April 15, 2000; 164(8): 4399 - 4407.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
J. D Cañete, S. E Martínez, J. Farrés, R. Sanmartí, M. Blay, A. Gómez, G. Salvador, and J. Muñoz-Gómez
Differential Th1/Th2 cytokine patterns in chronic arthritis: interferon gamma is highly expressed in synovium of rheumatoid arthritis compared with seronegative spondyloarthropathies
Ann Rheum Dis, April 1, 2000; 59(4): 263 - 268.
[Abstract] [Full Text]


Home page
Rheumatology (Oxford)Home page
Z. Yin, S. Siegert, L. Neure, M. Grolms, L. Liu, U. Eggens, A. Radbruch, J. Braun, and J. Sieper
The elevated ratio of interferon gamma-/ interleukin-4-positive T cells found in synovial fluid and synovial membrane of rheumatoid arthritis patients can be changed by interleukin-4 but not by interleukin-10 or transforming growth factor beta
Rheumatology, November 1, 1999; 38(11): 1058 - 1067.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Skapenko, J. Wendler, P. E. Lipsky, J. R. Kalden, and H. Schulze-Koops
Altered Memory T Cell Differentiation in Patients with Early Rheumatoid Arthritis
J. Immunol., July 1, 1999; 163(1): 491 - 499.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
M. S. LOMBARDI, A. KAVELAARS, M. SCHEDLOWSKI, J. W. J. BIJLSMA, K. L. OKIHARA, M. VAN DE POL, S. OCHSMANN, C. PAWLAK, R. E. SCHMIDT, and C. J. HEIJNEN
Decreased expression and activity of G-protein-coupled receptor kinases in peripheral blood mononuclear cells of patients with rheumatoid arthritis
FASEB J, April 1, 1999; 13(6): 715 - 725.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
B. Becher, M. Blain, P. S. Giacomini, and J. P. Antel
Inhibition of Th1 Polarization by Soluble TNF Receptor Is Dependent on Antigen-Presenting Cell-Derived IL-12
J. Immunol., January 15, 1999; 162(2): 684 - 688.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
C. M Verhoef, J. A G van Roon, M. E Vianen, F. P J G Lafeber, and J. W J Bijlsma
The immune suppressive effect of dexamethasone in rheumatoid arthritis is accompanied by upregulation of interleukin 10 and by differential changes in interferon gamma and interleukin 4 production
Ann Rheum Dis, January 1, 1999; 58(1): 49 - 54.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
S. Yoshino, Y. Murata, and M. Ohsawa
Successful Induction of Adjuvant Arthritis in Mice by Treatment with a Monoclonal Antibody Against IL-4
J. Immunol., December 15, 1998; 161(12): 6904 - 6908.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
M. CUTOLO, A. SULLI, B. VILLAGGIO, B. SERIOLO, and S. ACCARDO
Relations between steroid hormones and cytokines in rheumatoid arthritis and systemic lupus erythematosus
Ann Rheum Dis, October 1, 1998; 57(10): 573 - 577.
[Full Text]


Home page
Ann Rheum DisHome page
C. M Verhoef, J. A G van Roon, M. E Vianen, C. A F M Bruijnzeel-Koomen, F. P J G Lafeber, and J. W J Bijlsma
Mutual antagonism of rheumatoid arthritis and hay fever; a role for type 1/type 2 T cell balance
Ann Rheum Dis, May 1, 1998; 57(5): 275 - 280.
[Abstract] [Full Text]


Home page
Ann Rheum DisHome page
J. A G van Roon, C. M Verhoef, J. L A M van Roy, F. H J Gmelig-Meyling, O. Huber-Bruning, F. P J G Lafeber, and J. W J Bijlsma
Decrease in peripheral type 1 over type 2 T cell cytokine production in patients with rheumatoid arthritis correlates with an increase in severity of disease
Ann Rheum Dis, November 1, 1997; 56(11): 656 - 660.
[Abstract] [Full Text]


Home page
Ann Rheum DisHome page
A J G Swaak, H G van den Brink, and L A Aarden
Cytokine production in whole blood cell cultures of patients with rheumatoid arthritis
Ann Rheum Dis, November 1, 1997; 56(11): 693 - 695.
[Abstract] [Full Text]


Home page
JEMHome page
J. Punnonen, B. G. Cocks, J. M. Carballido, B. Bennett, D. Peterson, G. Aversa, and J. E. d. Vries
Soluble and Membrane-bound Forms of Signaling Lymphocytic Activation Molecule (SLAM) Induce Proliferation and Ig Synthesis by Activated Human B Lymphocytes
J. Exp. Med., March 17, 1997; 185(6): 993 - 1004.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.